valine has been researched along with organophosphonates in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (16.67) | 18.7374 |
1990's | 10 (27.78) | 18.2507 |
2000's | 14 (38.89) | 29.6817 |
2010's | 6 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Simon, JP; Stalon, V | 1 |
Dixon, HB; Southgate, CC | 1 |
Bartlett, PA; Kaplan, AP | 1 |
Chase, R; Gillam, IC; Tener, GM | 1 |
La Nauze, JM; Rosenberg, H | 1 |
Anderson, JW; Fewden, L | 1 |
Grünberger, D; Holý, A; Smrt, J; Sorm, F | 1 |
Banczerowski-Pelyhe, I; Csúcs, G; Tarnawa, I; Világi, I | 1 |
Reusser, P | 1 |
Charlton, J; Kirschenheuter, GP; Smith, D | 1 |
Cassady, KA; Whitley, RJ | 1 |
Ganem, D; Kedes, DH | 1 |
Keating, MR | 1 |
Torres, G | 1 |
Bowers, M | 1 |
Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V | 1 |
De Clercq, E; Naesens, L | 1 |
Snoeck, R | 1 |
Zaia, JA | 1 |
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
Dediulescu, DF; Dediulescu, L | 1 |
Morton, CJ; Ng, HL; Parker, MW; Rawlinson, WD; Scott, GM | 1 |
Goh, CL; Tan, HH | 1 |
Bound, F; Chandler, DS; Duncan, AM; Ren, H; Sandeman, RM; Tully, J | 1 |
Borysko, KZ; Breitenbach, JM; Drach, JC; Eriksson, U; Hilfinger, JM; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S | 1 |
Challacombe, SJ; Woo, SB | 1 |
Feng, YQ; Li, T; Lin, B; Yu, QW | 1 |
De Clercq, E | 1 |
He, YY; Li, FQ; Li, YQ; Lu, L; Sacktor, TC; Shaham, Y; Xu, CM; Xue, LF; Xue, YX | 1 |
Borysko, K; Breitenbach, J; Drach, JC; Hilfinger, J; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S; Peterson, LW | 1 |
Razonable, RR | 1 |
Bahar, MS; Boltežar, IH; Gale, N; Matičič, M; Poljak, M; Zargi, M | 1 |
Bertz, R; Bifano, M; Grasela, D; Hartstra, J; Hwang, C; Kandoussi, H; Oosterhuis, B; Sevinsky, H; Tiessen, R; Velinova-Donga, M | 1 |
Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J | 1 |
11 review(s) available for valine and organophosphonates
Article | Year |
---|---|
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1996 |
New therapeutic approaches to the alphaherpesvirus infections.
Topics: 2-Aminopurine; Acyclovir; Alphaherpesvirinae; Antibodies, Monoclonal; Arabinofuranosyluracil; Cidofovir; Cytosine; Famciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1997 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
Recent developments in herpesvirus therapy.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine | 2001 |
[Perspectives for the treatment and prevention of herpes simplex infections].
Topics: 2-Aminopurine; Acyclovir; Aminoquinolines; Antiviral Agents; Cidofovir; Cytosine; Drug Therapy, Combination; Famciclovir; Herpes Simplex; Herpes Simplex Virus Vaccines; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imiquimod; Interferon Inducers; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 2002 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
[Antiherpetic therapy].
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine | 2005 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine | 2006 |
Management of recurrent oral herpes simplex infections.
Topics: Acyclovir; Antiviral Agents; Bell Palsy; Cidofovir; Cytosine; Erythema Multiforme; Herpes Labialis; Humans; Immunocompromised Host; Organophosphonates; Secondary Prevention; Sunscreening Agents; Time Factors; Valacyclovir; Valine | 2007 |
The discovery of antiviral agents: ten different compounds, ten different stories.
Topics: Acyclovir; Adenine; Antiviral Agents; Benzodiazepines; Benzylamines; Cidofovir; Cyclams; Cytosine; Heterocyclic Compounds; Humans; Imidazoles; Nucleosides; Organophosphonates; Tenofovir; Valacyclovir; Valine; Virus Diseases | 2008 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
2 trial(s) available for valine and organophosphonates
Article | Year |
---|---|
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia | 1995 |
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Pyrrolidines; Ritonavir; Tenofovir; Valine; Viral Nonstructural Proteins; Young Adult | 2013 |
23 other study(ies) available for valine and organophosphonates
Article | Year |
---|---|
L-Ornithine carbamoyltransferase from Saccharomyces cerevisiae: steady-state kinetic analysis.
Topics: Aminobutyrates; Arsenates; Citrulline; Kinetics; Mathematics; Organophosphonates; Ornithine Carbamoyltransferase; Phosphates; Saccharomyces cerevisiae; Structure-Activity Relationship; Valine | 1977 |
Phosphonate analogues of aminoacyl adenylates.
Topics: Adenosine Monophosphate; Binding Sites; Drug Stability; Glycine; Kinetics; Organophosphonates; Valine; Valine-tRNA Ligase | 1978 |
Synthesis and evaluation of an inhibitor of carboxypeptidase A with a Ki value in the femtomolar range.
Topics: Carboxypeptidases; Carboxypeptidases A; Kinetics; Molecular Weight; Oligopeptides; Organophosphonates; Osmolar Concentration; Protease Inhibitors; Valine | 1991 |
Changes in levels of amino acid acceptors in tRNA from Escherichia coli grown under various conditions.
Topics: Amino Acyl-tRNA Synthetases; Aminobutyrates; Carbon Radioisotopes; Chromatography, DEAE-Cellulose; Densitometry; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Fluorine; Mutation; Organophosphonates; Phenylalanine; RNA, Bacterial; RNA, Transfer; Spectrophotometry, Ultraviolet; Temperature; Threonine; Time Factors; Transfer RNA Aminoacylation; Tyrosine; Valine | 1974 |
The metabolism of phosphonates by microorganisms. The transport of aminoethylphosphonic acid in Bacillus cereus.
Topics: Amines; Bacillus cereus; Bacterial Proteins; Biological Transport; Chloramphenicol; Culture Media; Dactinomycin; Dinitrophenols; Glucose; Iodoacetates; Kinetics; Mutation; Organophosphonates; Oxygen; Phosphates; Phosphorus Isotopes; Tritium; Valine | 1967 |
1-amino-2-phenylethane 1-phosphonic acid: a specific competitive inhibitor of phenylalanyl-tRNA synthetase.
Topics: Amino Acyl-tRNA Synthetases; Kinetics; Leucine; Organophosphonates; Phenylalanine; Plants; Threonine; Tyrosine; Valine | 1970 |
Synthesis of a GpUpU analogue containing 5'-deoxyuridine 5'-phosphonic acid and its effect upon the binding of [14C]valyl- and [14C]alanyl-tRNA to ribosomes.
Topics: Alanine; Animals; Carbon Isotopes; Genetic Code; Organophosphonates; Ribosomes; RNA, Transfer; Snakes; Uracil Nucleotides; Valine; Venoms | 1967 |
An increased intensity of N-methyl-D-aspartate (NMDA) but not non-NMDA receptor activation may be responsible for the enhancement of excitatory processes in the neocortex of two-week-old rats: a brain slices study.
Topics: Action Potentials; Animals; Animals, Suckling; Benzodiazepines; Binding, Competitive; Cerebral Cortex; Electric Stimulation; Excitatory Amino Acid Antagonists; Organophosphonates; Pentanoic Acids; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Somatosensory Cortex; Synaptic Transmission; Valine | 1996 |
Highly potent irreversible inhibitors of neutrophil elastase generated by selection from a randomized DNA-valine phosphonate library.
Topics: Cathepsin G; Cathepsins; Fluorescein; Fluoresceins; Fluorescence; Gene Library; Humans; Kinetics; Leukocyte Elastase; Models, Chemical; Molecular Conformation; Neutrophils; Nucleic Acid Conformation; Oligodeoxyribonucleotides; Organophosphonates; Salts; Sequence Analysis; Serine Endopeptidases; Serine Proteinase Inhibitors; Substrate Specificity; Valine | 1997 |
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
Herpesviruses.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Complementary Therapies; Cytosine; Famciclovir; Foscarnet; Herpesviridae Infections; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine; Viral Vaccines | 1995 |
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation | 2001 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine | 2002 |
Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.
Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Valacyclovir; Valganciclovir; Valine | 2002 |
Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Ganciclovir; Guanine; Humans; Mice; Models, Molecular; Molecular Sequence Data; Muromegalovirus; Mutation; Organophosphonates; Protein Kinases; Sequence Alignment; Valacyclovir; Valine; Virus Replication | 2005 |
Assessment of novel inhibitors of Helicoverpa aminopeptidases as anti-insect agents.
Topics: Aminopeptidases; Animals; Hydroxamic Acids; Insecticides; Larva; Moths; Organophosphonates; Organophosphorus Compounds; Phthalimides; Tetralones; Valine | 2006 |
Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
Topics: Amino Acids; Animals; Antiviral Agents; Biological Availability; Biotransformation; Cell Survival; Cidofovir; Cytosine; Ethylene Glycol; Half-Life; Humans; Hydrolysis; KB Cells; Magnetic Resonance Spectroscopy; Organophosphonates; Peptide Transporter 1; Phenylalanine; Prodrugs; Rats; Symporters; Valine; Viral Plaque Assay | 2007 |
Synthesis and chromatographic properties of a chiral stationary phase derived from bovine serum albumin immobilized on magnesia-zirconia using phosphonate spacers.
Topics: Animals; Cattle; Chromatography, Liquid; Dansyl Compounds; Dinitrobenzenes; Fosfomycin; Leucine; Magnesium Oxide; Molecular Structure; Organic Chemicals; Organophosphonates; Pharmaceutical Preparations; Phenylalanine; Serum Albumin, Bovine; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Temperature; Tryptophan; Valine; Zirconium | 2007 |
Inhibition of PKMzeta in nucleus accumbens core abolishes long-term drug reward memory.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Endocytosis; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Male; Memory; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Oligopeptides; Organophosphonates; Piperazines; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Reward; Substance Withdrawal Syndrome; Time Factors; Valine | 2011 |
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates; Peptides; Prodrugs; Rats; Serine; Valine | 2011 |
Adjuvant therapy for laryngeal papillomatosis.
Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Antiviral Agents; Chemotherapy, Adjuvant; Child; Child, Preschool; Cidofovir; Cytosine; Female; Humans; Indoles; Infant; Laryngeal Diseases; Male; Middle Aged; Organophosphonates; Papilloma; Papillomavirus Vaccines; Vaccination; Valacyclovir; Valine | 2011 |
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Resistance, Viral; Drugs, Investigational; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Investigational New Drug Application; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphonates; Transplantation, Homologous; Valacyclovir; Valine | 2016 |